Dizone

Quick links to important sections

Dizone

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dizone

What is Dizone? Dual-Action Combination Medicine

Property Description
Active Ingredients Disulfiram and Pioglitazone
Form Oral tablet
Pharmacological Class Alcohol Deterrent Drug and Hypoglycemic Agent
General Purpose Simultaneous support for abstinence and glycemic control
Origin Synthetic compound

Dizone: Identity and Pharmaceutical Classification

Dizone is a unique prescription-only medication classified as a fixed-dose combination product, delivered for oral administration as a synthetic oral tablet. This formulation is distinct because it strategically combines two pharmaceutical agents from entirely different pharmacological classes. The medication's dual nature stems from combining an Alcohol Deterrent Drug with a Hypoglycemic Agent (Antidiabetic Agent). Its design serves patients who require simultaneous intervention for two separate therapeutic areas, offering a simplified approach to complex co-occurring conditions, a strategy that is clinically recognized for improving patient adherence in dual diagnoses.


Composition and General Therapeutic Purpose

  • The core function of Dizone is based on its two distinct active ingredients: Disulfiram and Pioglitazone. Disulfiram acts as an Aldehyde Dehydrogenase Inhibitor, while Pioglitazone is classified as a Thiazolidinedione (TZD), a class recognized for its ability to increase insulin sensitivity.
  • The TZD class is known to help improve the body's response to insulin, which is particularly relevant for individuals managing a chronic metabolic disorder. The primary general purpose is the concurrent management of alcohol use disorder and Type 2 diabetes mellitus. By combining the effect of Disulfiram, which supports abstinence by creating an alcohol deterrent, with Pioglitazone's aid in glycemic control, the drug addresses both conditions in a single pharmaceutical unit.

What side effects are possible with Dizone?

Possible Side Effects and Safety Information

The safety profile of Dizone, a fixed-dose combination of Disulfiram and Pioglitazone, is structured by the known risks of each active ingredient, as documented in regulatory sources.

Adverse Reaction Classifications

The most serious risk associated with the Disulfiram component is the potentially fatal Disulfiram-Alcohol Reaction, which can be precipitated by alcohol ingestion up to 14 days after stopping the medication. Both components carry a risk of severe Hepatic Failure, which may develop even after prolonged therapy. Common side effects, classified as Very Common (ge 10%) in regulatory data for the Pioglitazone component, include edema (fluid retention), increased weight, and upper respiratory tract infection.

System-Organ Class Key Adverse Reactions (Label-Documented)
Hepatobiliary Disorders Hepatic failure, hepatitis
Cardiac Disorders Congestive Heart Failure (including fatal cases)
Nervous System Disorders Peripheral neuropathy, optic neuritis, headache
Musculoskeletal System Bone fractures (increased risk in women)

Serious Safety Constraints

Official prescribing information documents specific, serious safety risks for Pioglitazone, including an increased risk of Bladder Cancer and the development of Congestive Heart Failure (CHF). The medication is contraindicated in patients with established NYHA Class III or IV heart failure, active bladder cancer, or severe hepatic impairment.

Population-Specific Notes

Safety constraints apply to specific populations. Due to the risk of fluid retention, monitoring for signs of CHF is crucial, particularly after treatment initiation or a dose increase. Pioglitazone may induce ovulation in premenopausal anovulatory women, a consideration defined in regulatory labeling.

Overdose and Emergency Response

The official regulatory profile for Dizone overdose addresses the toxicological risks associated with its two active components. Manifestations of an overdose may include CNS effects such as dizziness, drowsiness, excitement, and loss of coordination, alongside gastrointestinal effects like nausea and vomiting. A critical concern documented in regulatory sources is the potential for Severe Hypoglycemia, which may present as confusion, profuse sweating, or tremor.

Severe or Life-Threatening Manifestations
Seizure, Coma, Unconsciousness, Respiratory depression, and Cardiovascular collapse are documented severe outcomes. Exacerbation of Acute congestive heart failure is also noted as a risk in official labeling.

Immediate medical attention is required for all suspected cases. You must contact emergency services immediately if the affected person shows signs of collapse, trouble breathing, seizure, or is unable to be awakened, as these are classified as life-threatening events in the official regulatory guidance. Increased risk of severe outcome is also documented for patients with severe heart disease or hepatic impairment.

Treatment is defined as symptomatic and supportive, given that regulatory documents explicitly state that no specific antidote is known for the Disulfiram component. Required management involves hospital monitoring with careful observation of cardiovascular and respiratory status, and frequent monitoring of plasma glucose levels.

Therapeutic Uses of Dizone

Dizone is relevant for patients managing the complexity of coexisting chronic conditions: Alcohol Use Disorder and Type 2 Diabetes Mellitus. The agent is commonly used across conditions involving episodic or fluctuating manifestations, such as high blood sugar.


What Dizone Treats: Main Uses and Benefits

Dizone is commonly used to help with managing symptoms that create noticeable physiological strain, linked to alcohol dependence, and to help address symptom clusters, such as hyperglycemia and uncontrolled high blood sugar, in adults with Type 2 Diabetes Mellitus (T2DM). The medication may be part of symptomatic management, supporting both a metabolic disorder and a dependency issue concurrently.

It is considered relevant for easing distress and supporting patients during episodes of heightened discomfort associated with alcohol use disorder, while the medication is considered relevant for easing symptoms related to systemic imbalance in T2DM. The medication may be part of symptomatic management in situations where symptoms may intensify temporarily due to the dual diagnosis.

Quick Fact: Symptomatic Support
Dizone is applied in addressing two therapeutic domains: symptoms related to physiological strain linked to alcohol dependence, and symptoms related to systemic imbalance in T2DM.

Regulatory References

  1. NIH MedlinePlus overview of pioglitazone

Eligibility and Restrictions for Use

Official Eligibility Profile

The eligibility for Dizone (Disulfiram and Pioglitazone) is defined by a strict set of rules from regulatory authorities, addressing both the required medical condition and high-risk exclusions.

Classification Eligibility Statement (Regulatory Basis)
Approved Population Adults with Type 2 Diabetes Mellitus are the eligible age group for whom use is established.
Absolute Contraindications Patients with established NYHA Class III or IV heart failure or active liver disease must not use the medicine. Absolute prohibition applies to those who have consumed alcohol within the last 12 hours or who are taking Metronidazole or Paraldehyde. Contraindications also include active bladder cancer or hypersensitivity to either active ingredient.
Conditional Use Use requires caution and close monitoring in patients with NYHA Class I or II heart failure or a prior history of bladder cancer.
Age Restriction Pediatric use (under 18 years) is not recommended as safety and efficacy have not been established.
Reproductive Status The medicine is not recommended during pregnancy or breastfeeding. Females of reproductive potential must be advised of the potential for unintended pregnancy.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Dizone is strictly defined by government regulatory documents and involves mandatory prohibitions and required adjustments. Co-administration with Alcohol (including alcohol-containing preparations), Metronidazole, and Paraldehyde is strictly contraindicated. Initiation of therapy requires an abstinence period of at least 12 hours from alcohol, and the associated reaction risk persists for up to 14 days after stopping treatment.


The Pioglitazone component is subject to pharmacokinetic interactions. Strong CYP2C8 Inhibitors like Gemfibrozil increase Pioglitazone exposure by approximately three-fold, requiring a dose limitation of 15 mg daily. The Disulfiram component inhibits CYP450 enzymes, increasing the serum concentrations of co-administered drugs such as Phenytoin (risk of intoxication) and Warfarin (prolonged prothrombin time).


Pharmacodynamic interactions include an increased risk of hypoglycemia when Pioglitazone is combined with Insulin or Sulfonylureas. Pioglitazone also reduces the plasma concentrations of Oral Contraceptives by approximately 30%. Caution is noted for elderly patients due to potential changes in drug clearance and an increased risk of heart failure when the Pioglitazone component is combined with Insulin.

Mechanism of Action

Dizone employs two distinct and independent pharmacological actions to modulate two separate physiological systems.

Enzyme Inhibition for Acute Physiological Response

This domain focuses on the action of Disulfiram, which causes an irreversible inhibition of the Aldehyde Dehydrogenase (ALDH) enzyme, a key component of the ethanol clearance pathway. This enzymatic blockade leads to the rapid, systemic accumulation of the toxic metabolite acetaldehyde, which, in turn, induces profound vasomotor instability and rapid physiological changes. This mechanism is entirely substrate-dependent and is the direct cause of the drug's predictable acute physiological response to ethanol.

Nuclear Receptor Activation for Metabolic Pathway Modulation

The second domain involves Pioglitazone, which functions as a selective agonist of the PPARgamma nuclear receptor, primarily in adipose cells. This activation leads to a change in gene transcription, altering the cellular expression of glucose transporters and modifying the tissue's responsiveness to insulin. The resulting physiological consequence is a long-term enhancement of peripheral glucose utilization and modulation of lipid partitioning, influencing overall systemic metabolic processes.

Dosage and Administration Information

Dizone, which contains the active ingredient disulfiram, is an oral tablet taken once daily. The medicine should never be administered until the patient has abstained from alcohol for at least 12 hours or 24 hours. Administration must be conducted only with the full knowledge and consent of the patient.

Standard Dosing Regimen

The dosage involves two phases:

  1. Initial Dosage Phase: A maximum of 500 mg is typically given once daily in a single dose for the first one to two weeks.
  2. Maintenance Regimen: The average dose is 250 mg once daily, with a range between 125 mg and 500 mg. The daily dose should not exceed 500 mg.

Continuous daily administration may be required for months or years, depending on the established basis for self-control, and the maintenance dose should be periodically reviewed.

Administration Instructions

The tablet is usually taken in the morning. However, if the patient experiences a sedative effect, the dose may be taken at bedtime. The tablet may be swallowed whole or, if needed, can be crushed and mixed with liquid such as water, coffee, tea, milk, or fruit juice before taking. Taking the drug with food may increase its absorption.

Special Dosing Considerations

  • Missed Dose: If a dose is missed, the patient should take the next scheduled dose at the usual time; do not take double or extra doses to compensate for the missed one.
  • Pediatric and Elderly Use: Safety and effectiveness in children have not been established. Dose selection for elderly patients should be cautious, generally starting at the low end of the dosing range, due to the higher frequency of decreased organ function.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Dizone


Evidence for the Dual Diagnosis: Alcohol Use Disorder and Type 2 Diabetes

Research for the specific Dizone combination is characterized by early-stage studies, including pilot and feasibility studies and some ongoing Randomized Controlled Trials (RCTs). These investigations research examined whether it is practical and acceptable for patients to take a single tablet combining the two components. Researchers monitored outcomes related to both abstinence (using biological tests) and glycemic control (tracking HbA1c and Fasting Blood Glucose levels), which are outcomes related to systemic or functional imbalance. Currently, certainty remains low, and the evidence is limited. Long-term effects are not fully established for the fixed-dose combination, and data for certain groups remain insufficient.


Evidence for Support of Abstinence in Alcohol Use Disorder

Studies of the Disulfiram component was studied for use in adults with Alcohol Use Disorder, primarily through RCTs and meta-analyses. The studies monitored outcomes such as total abstinence rates and the overall volume of alcohol consumption. Trials reported observed patterns in short-term abstinence which were observed to be associated with supervised administration. The results apply only to the populations studied, and there is limited information for long-term outcomes in unsupervised settings.


Evidence for Glycemic Control in Type 2 Diabetes Mellitus

The research base for the Pioglitazone component was evaluated in numerous large-scale RCTs. These studies primarily monitored changes in key biomarkers such as HbA1c and Fasting Plasma Glucose (FPG) levels in adults with T2DM. Long-term studies, with follow-up durations extending up to five years, research examined cardiovascular event rates. Reported outcomes described changes in measures of insulin sensitivity across many populations studied. Research has not studied the drug for use in children or adolescents, and subgroup findings are uncertain when assessing specific secondary endpoints.

Key Studies & References

  1. Pioglitazone (Oral Route) - NIH MedlinePlus
  2. FDA Label: PIOGLITAZONE - pioglitazone hydrochloride tablet

Frequently Asked Questions (FAQ)

Common questions about Dizone (FAQ)

Q: Is it safe to drink alcohol while taking Dizone?

Regulatory documents state that co-administration with alcohol is strictly contraindicated (prohibited). This is due to the risk of a highly unpleasant, potentially fatal Disulfiram-Alcohol Reaction. The associated reaction risk persists for up to 14 days after stopping treatment.


Q: Are there any specific foods to avoid while using Dizone?

Official information indicates that you should avoid alcohol-containing preparations while using this medicine. This includes products such as certain cough syrups, tonics, or mouthwashes. Official documents list no specific restrictions for common foods.


Q: Is Dizone available over the counter?

No. Dizone is classified as a prescription-only medication. As a prescription-only medication, it is dispensed by a pharmacist following a valid prescription.


Q: How is Dizone different from similar drugs?

Dizone is classified as a fixed-dose combination product. Its formulation is notable because it combines two agents from entirely separate pharmacological classes: an Alcohol Deterrent Drug (Disulfiram) and a Hypoglycemic Agent (Pioglitazone). This design is intended to address two different therapeutic needs simultaneously in a single medicine.


Q: Can Dizone be used to treat headaches?

The medicine is officially indicated for the concurrent management of alcohol use disorder and Type 2 diabetes mellitus. Headache is listed in regulatory documents as a potential side effect of the medicine, not a condition for treatment.


Q: Does Dizone cause drowsiness or make you tired?

Official information states that the dose may be taken at bedtime if a patient experiences a sedative effect. The adverse reaction profile for the medicine may also include non-specific symptoms such as fatigue or unusual tiredness.


Q: Is Dizone known to cause weight changes?

Yes, official regulatory data for one of the drug's components, Pioglitazone, classifies increased weight as a Very Common side effect. This means it is among the most frequently reported side effects in official data.


Q: What happens if I miss a dose of Dizone?

Official labeling states that the next scheduled dose should be taken at the usual time. It is specifically noted that you should not take double or extra doses to try and compensate for the missed one.


Q: Does Dizone affect birth control pills?

Official labeling states that the Pioglitazone component of Dizone reduces the plasma concentrations of Oral Contraceptives by approximately 30%. Official labeling notes that females of reproductive potential should be advised of the potential for unintended pregnancy.


Q: Is Dizone suitable for older adults (seniors)?

The official information notes that dose selection for elderly patients requires caution. This is because seniors often have a higher frequency of decreased organ function, and official information advises that dose selection should generally start at the low end of the established range for older adults.


Q: What are the restrictions on driving or operating machinery while taking Dizone?

The drug's official documents note that it can cause a sedative effect and side effects like headache. Based on these potential effects, regulatory information advises caution when performing tasks that require full attention, such as driving or operating heavy machinery.


Q: Can Dizone interact with common pain relievers?

Regulatory documents explicitly contraindicate (prohibit) co-administration with Alcohol, Metronidazole, and Paraldehyde, and note risks with certain anticoagulants (Warfarin) and anticonvulsants (Phenytoin). Official documents do not include a general statement regarding all common non-prescription pain relievers.


Q: How long does it typically take to feel the effects of Dizone?

For the alcohol-deterrent component, the severe Disulfiram-Alcohol Reaction can occur rapidly after alcohol ingestion. For the glycemic (sugar-lowering) component, clinical studies show effects often persist for at least one year. The regulatory information does not provide a single fixed onset time for the full therapeutic effects.


Q: Is Dizone safe for people with kidney problems?

While the official labeling has strong contraindications related to active liver disease, it notes specific information for kidney function. Official regulatory information describes the elimination of the Pioglitazone component as unchanged in patients with moderate to severe renal impairment.


Q: Is it common for Dizone to cause stomach upset?

The adverse reaction profile of the Pioglitazone component can include gastrointestinal symptoms. Regulatory information documents that the adverse reaction profile of the Pioglitazone component can include gastrointestinal symptoms such as stomach pain, nausea, or vomiting.


Q: Is Dizone safe to take long-term?

Regulatory documents state that continuous daily administration may be required for months or years. However, research evidence summaries indicate that the long-term effects are not fully established for the fixed-dose combination.


Q: Do studies suggest Dizone is effective for all conditions it is approved for?

Official research summaries indicate that the evidence is limited and certainty remains low for the fixed-dose combination. Results for the single agents apply only to the specific populations studied in those trials.


Q: Does Dizone affect laboratory test results?

Official information requires obtaining and monitoring specific liver tests prior to and during therapy. Additionally, the drug is described as influencing biomarkers such as HbA1c and Fasting Blood Glucose.


Q: What is the difference between brand name Dizone and its generic version?

Government policy defines that generic versions are required to be the same as the brand-name drug in terms of active ingredient, strength, dosage form, and route of administration. A generic product is required to prove bioequivalence to the brand name, meaning it acts the same way in the body.

How should Dizone be stored and disposed of?

Storage and Disposal Conditions for Dizone

Dizone (Disulfiram/Pioglitazone) must be stored and handled according to specific regulatory requirements to maintain its stability and ensure safety.


Storage Requirements

Store the tablets at Controlled Room Temperature, defined as 20^circ to 25 C (68^circ to 77 F), with permitted short excursions. The medicine must be kept out of the sight and reach of children and stored in the original, tightly closed container.

It is mandatory to protect Dizone from light and moisture.


Disposal Instructions

Unused or expired Dizone should preferably be returned to a drug take-back program. If this is not available, the medication must be mixed with an undesirable substance (such as used coffee grounds) and placed in a sealed container before being thrown in the household trash. Do not flush these tablets down the toilet or pour down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Dizone found in:

A-Z Index: